{"id":41428,"date":"2025-09-15T17:04:14","date_gmt":"2025-09-15T09:04:14","guid":{"rendered":"https:\/\/flcube.com\/?p=41428"},"modified":"2025-09-15T17:04:15","modified_gmt":"2025-09-15T09:04:15","slug":"zsco-invests-790-m-rmb-in-guobang-pharma-launches-strategic-partnership","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=41428","title":{"rendered":"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership"},"content":{"rendered":"\n<p><strong>Zhejiang State\u2011owned Capital Operation Co., Ltd. (ZSCO)<\/strong> and <strong>Guobang Pharmaceutical (<a href=\"https:\/\/www.google.com\/finance\/quote\/605507:SHA\">SHA: 605507<\/a>)<\/strong> announced a strategic partnership aimed at accelerating Guobang\u2019s multi\u2011sector expansion. ZSCO has injected <strong>RMB\u202f790\u202fmillion<\/strong> into the company through a negotiated transfer, acquiring a <strong>6.85\u202f% stake<\/strong> that positions the state\u2011owned asset manager as a key growth enabler.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-investment-highlights\">Investment Highlights<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Capital Injection<\/strong> \u2013 RMB\u202f790\u202fmillion provides Guobang with fresh liquidity to pursue aggressive growth in high\u2011margin sectors such as pet drugs, novel drug discovery, contract development &amp; manufacturing organization (CDMO) services, and advanced materials.<\/li>\n\n\n\n<li><strong>Strategic Alignment<\/strong> \u2013 ZSCO\u2019s investment is complemented by its long\u2011term commitment to support Guobang\u2019s expansion, including industry mergers &amp; acquisitions, technology partnerships, and global market entry.<\/li>\n\n\n\n<li><strong>Governance &amp; Oversight<\/strong> \u2013 ZSCO will secure board representation and participate in strategic decision\u2011making, ensuring alignment of objectives between the state\u2011owned investor and the publicly listed company.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-future-growth-strategy\">Future Growth Strategy<\/h3>\n\n\n\n<p>Guobang plans to leverage the partnership to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Scale Pet Drug Portfolio<\/strong> \u2013 Expand its pipeline of veterinary therapeutics, capitalizing on a growing global pet\u2011care market.<\/li>\n\n\n\n<li><strong>Accelerate New\u2011Drug R&amp;D<\/strong> \u2013 Deploy increased R&amp;D budget toward high\u2011potential indications, leveraging ZSCO\u2019s industrial network for technology transfer.<\/li>\n\n\n\n<li><strong>Build CDMO Capabilities<\/strong> \u2013 Expand contract manufacturing services to serve both domestic and international clients, creating a new revenue stream.<\/li>\n\n\n\n<li><strong>Develop New Materials<\/strong> \u2013 Invest in next\u2011generation biomaterials and delivery systems to support both pharmaceutical and medical\u2011device applications.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-vision-for-a-global-life-tech-hub\">Vision for a Global Life\u2011Tech Hub<\/h3>\n\n\n\n<p>The partnership aims to transform Guobang into a <strong>globally influential life and health technology innovation hub<\/strong>. By combining ZSCO\u2019s capital resources, industrial expertise, and strategic network with Guobang\u2019s commercial momentum and product pipeline, the alliance is poised to deliver sustained value to shareholders while advancing China\u2019s position in the global life\u2011science arena.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zhejiang State\u2011owned Capital Operation Co., Ltd. (ZSCO) and Guobang Pharmaceutical (SHA: 605507) announced a strategic&#8230;<\/p>\n","protected":false},"author":1,"featured_media":41430,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4352,4353],"class_list":["post-41428","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-guobang-pharmaceutical","tag-sha-605507"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Zhejiang State\u2011owned Capital Operation Co., Ltd. (ZSCO) and Guobang Pharmaceutical (SHA: 605507) announced a strategic partnership aimed at accelerating Guobang\u2019s multi\u2011sector expansion. ZSCO has injected RMB\u202f790\u202fmillion into the company through a negotiated transfer, acquiring a 6.85\u202f% stake that positions the state\u2011owned asset manager as a key growth enabler.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=41428\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership\" \/>\n<meta property=\"og:description\" content=\"Zhejiang State\u2011owned Capital Operation Co., Ltd. (ZSCO) and Guobang Pharmaceutical (SHA: 605507) announced a strategic partnership aimed at accelerating Guobang\u2019s multi\u2011sector expansion. ZSCO has injected RMB\u202f790\u202fmillion into the company through a negotiated transfer, acquiring a 6.85\u202f% stake that positions the state\u2011owned asset manager as a key growth enabler.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=41428\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-15T09:04:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-15T09:04:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1510.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41428#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41428\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership\",\"datePublished\":\"2025-09-15T09:04:14+00:00\",\"dateModified\":\"2025-09-15T09:04:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41428\"},\"wordCount\":310,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41428#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1510.webp\",\"keywords\":[\"Guobang Pharmaceutical\",\"SHA: 605507\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41428#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41428\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=41428\",\"name\":\"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41428#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41428#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1510.webp\",\"datePublished\":\"2025-09-15T09:04:14+00:00\",\"dateModified\":\"2025-09-15T09:04:15+00:00\",\"description\":\"Zhejiang State\u2011owned Capital Operation Co., Ltd. (ZSCO) and Guobang Pharmaceutical (SHA: 605507) announced a strategic partnership aimed at accelerating Guobang\u2019s multi\u2011sector expansion. ZSCO has injected RMB\u202f790\u202fmillion into the company through a negotiated transfer, acquiring a 6.85\u202f% stake that positions the state\u2011owned asset manager as a key growth enabler.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41428#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41428\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41428#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1510.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1510.webp\",\"width\":1080,\"height\":608,\"caption\":\"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41428#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership - Insight, China&#039;s Pharmaceutical Industry","description":"Zhejiang State\u2011owned Capital Operation Co., Ltd. (ZSCO) and Guobang Pharmaceutical (SHA: 605507) announced a strategic partnership aimed at accelerating Guobang\u2019s multi\u2011sector expansion. ZSCO has injected RMB\u202f790\u202fmillion into the company through a negotiated transfer, acquiring a 6.85\u202f% stake that positions the state\u2011owned asset manager as a key growth enabler.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=41428","og_locale":"en_US","og_type":"article","og_title":"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership","og_description":"Zhejiang State\u2011owned Capital Operation Co., Ltd. (ZSCO) and Guobang Pharmaceutical (SHA: 605507) announced a strategic partnership aimed at accelerating Guobang\u2019s multi\u2011sector expansion. ZSCO has injected RMB\u202f790\u202fmillion into the company through a negotiated transfer, acquiring a 6.85\u202f% stake that positions the state\u2011owned asset manager as a key growth enabler.","og_url":"https:\/\/flcube.com\/?p=41428","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-15T09:04:14+00:00","article_modified_time":"2025-09-15T09:04:15+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1510.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=41428#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=41428"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership","datePublished":"2025-09-15T09:04:14+00:00","dateModified":"2025-09-15T09:04:15+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=41428"},"wordCount":310,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=41428#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1510.webp","keywords":["Guobang Pharmaceutical","SHA: 605507"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=41428#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=41428","url":"https:\/\/flcube.com\/?p=41428","name":"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=41428#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=41428#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1510.webp","datePublished":"2025-09-15T09:04:14+00:00","dateModified":"2025-09-15T09:04:15+00:00","description":"Zhejiang State\u2011owned Capital Operation Co., Ltd. (ZSCO) and Guobang Pharmaceutical (SHA: 605507) announced a strategic partnership aimed at accelerating Guobang\u2019s multi\u2011sector expansion. ZSCO has injected RMB\u202f790\u202fmillion into the company through a negotiated transfer, acquiring a 6.85\u202f% stake that positions the state\u2011owned asset manager as a key growth enabler.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=41428#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=41428"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=41428#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1510.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1510.webp","width":1080,"height":608,"caption":"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=41428#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"ZSCO Invests 790\u202fm RMB in Guobang Pharma, Launches Strategic Partnership"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1510.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41428"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41428\/revisions"}],"predecessor-version":[{"id":41431,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41428\/revisions\/41431"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/41430"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}